tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Justin Kim, 56 are a BUY (88.89%), 7 are a HOLD (11.11%).
Analyst Justin Kim, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 57.89% that have a potential upside of 64.03% achieved within 229 days.
Justin Kim’s has documented 121 price targets and ratings displayed on 12 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on IMCR, Immunocore Holdings Ltd at 07-Nov-2024.
Analyst best performing recommendations are on AUPH (AURINIA PHARMACEUTICALS).
The best stock recommendation documented was for AUPH (AURINIA PHARMACEUTICALS) at 10/28/2021. The price target of $32 was fulfilled within 1 day with a profit of $2.04 (6.81%) receiving and performance score of 68.09.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$28
2 years 7 months 17 days ago
(18-Jul-2022)
1/4 (25%)
$15.6 (125.81%)
169
Hold
$8
2 years 8 months 5 days ago
(30-Jun-2022)
2/2 (100%)
$-18.1 (-69.35%)
282
Hold
$5
$-5 (-50.00%)
$15
2 years 8 months 5 days ago
(30-Jun-2022)
3/3 (100%)
$-6.4 (-56.14%)
193
Which stock is Justin Kim is most bullish on?
Which stock is Justin Kim is most reserved on?
What Year was the first public recommendation made by Justin Kim?
